A joint project of the Graduate School, Peabody College, and the Jean & Alexander Heard Library

Title page for ETD etd-06222007-085004


Type of Document Master's Thesis
Author Duell, Stephanie
URN etd-06222007-085004
Title Kaposi's Sarcoma Associated Herpesvirus-Encoded Cyclin, K-cyclin Enhance NF-kappa B Dependent Transcription And Interacts With Latency-Associated Nuclear Antigen In Virally and Non-Virally Infected Cells
Degree Master of Science
Department Cancer Biology
Advisory Committee
Advisor Name Title
Stephen Brandt, MD Committee Chair
Jin Chen, PhD Committee Member
Philip Browning, MD Committee Member
Keywords
  • Transcription factors
  • Viral antigens
  • cyclin regulated transcription
  • HHV-8
  • viral oncology
  • Cyclins -- Physiological effect
Date of Defense 2007-08-01
Availability unrestricted
Abstract
Kaposi's sarcoma Herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma, primary effusion lymphoma (PEL) and multicentric Castlemen's disease (MCD). This ƒ×-herpesvirus infects endothelial cells lining the vascular spaces of KS lesions, the so-called spindle cells and B cells in PEL. KSHV encodes proteins that mimic the actions of cellular proteins and override normal cell cycle checkpoints. Viral Bcl-2 and Flice-like inhibitory protein (v-FLIP) contribute to increased cell survival, while a virally-encoded G protein-coupled receptor and viral IL-6 regulate cell growth.

K-cyclin, the cyclin D2 homolog, has non-cell cycle-related transcriptional regulatory properties. Data from our laboratory demonstrates that K-cyclin associates with the transcriptionally active S1 fraction of chromatin along with other proteins like p300, polymerase II and transcription factor IID (TFIID) known to be involved in transcription. K-cyclin/cdk6 complexes can bind and phosphorylate p300, and by doing so activate NF-ƒÛB dependent transcription. This is significant because our lab's work shows that K-cyclin's activity contributes to the constitutive activation of the NF-kappaB transcriptional pathway in HHV8-associated tumors. K-cyclin contains a protein docking site near the amino terminus, termed the MRAIL motif. This conserved site allows cellular cyclins to interact with proteins containing RXL motifs. We questioned whether the MRAIL motif was essential for the K-cyclin/p300 interaction and the subsequent activation of NF-kappaB-dependent transcription. To answer this question, using site-directed mutagenesis we generated alanine mutants of the amino acid residues comprising the MRAIL motif. We have found that the mutation of any single amino acid in the MRAIL motif is sufficient to disrupt the ability of K-cyclin to activate NF-kappaB-dependent transcription using an NF-kappaB luciferase reporter assay.

The three most important latency genes, v-FLIP, K-cyclin and LANA are under the control of the same promoter, with both LANA and K-cyclin having emerging roles as transcriptional regulators. As K-cyclin and LANA are both transcribed from a single promoter, are expressed at the same time in the viral life cycle and are both found in the nucleus, we sought to determine whether they physically interact. We have identified a novel association between K-cyclin and LANA, a multifunctional viral protein involved in transcription by interacting directly with DNA and through protein-protein interactions with other transcription factors like AP-1, Sp1 and pRb. This interaction was detected at endogenous levels of both proteins in a PEL cell line by coimmunoprecipitation analysis in both directions. Finally, studies in transfected COS-7L cells suggest that K-cyclin-LANA interation is not dependent on any other viral proteins. These findings suggest that K-cyclin is a transcriptional regulator and that this association may play a role in the signature NF-kappaB activation found in KSHV-infected cells.

Files
  Filename       Size       Approximate Download Time (Hours:Minutes:Seconds) 
 
 28.8 Modem   56K Modem   ISDN (64 Kb)   ISDN (128 Kb)   Higher-speed Access 
  thesis.pdf 348.66 Kb 00:01:36 00:00:49 00:00:43 00:00:21 00:00:01

Browse All Available ETDs by ( Author | Department )

If you have more questions or technical problems, please Contact LITS.